Is Amazon Stock Still Worth Staking On?
Amazon.com Inc (NASDAQ: AMZN) posted one of its strongest years…
Buy
52
GHC Quote, Financials, Valuation and Earnings
Last price:
$940.09
Seasonality move
:
3.37%
Day range:
$935.42 - $947.75
52-week range:
$683.00 - $993.49
Dividend yield:
0.74%
P/E ratio:
5.70x
P/S ratio:
0.86x
P/B ratio:
0.96x
Volume:
87.4K
Avg. volume:
21.1K
1-year change:
25.68%
Market cap:
$4.1B
Revenue:
$4.8B
EPS (TTM):
$164.90
| Period Ending | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | |
|---|---|---|---|---|---|---|
| Revenue | $2.9B | $3.2B | $3.9B | $4.4B | $4.8B | |
| Revenue Growth (YoY) | -1.47% | 10.28% | 23.18% | 12.5% | 8.52% | |
| Cost of Revenues | $1.9B | $2.1B | $2.7B | $3.1B | $3.3B | |
| Gross Profit | $977M | $1.1B | $1.3B | $1.3B | $1.5B | |
| Gross Profit Margin | 33.82% | 33.63% | 32.28% | 29.72% | 30.61% | |
| R&D Expenses | -- | -- | -- | -- | -- | |
| Selling, General & Admin | $715.4M | $831.9M | $921.7M | $1B | $1.1B | |
| Other Inc / (Exp) | $311.1M | $369.8M | -$40M | $186.7M | $935.7M | |
| Operating Expenses | $846.4M | $961.1M | $1.1B | $1.1B | $1.2B | |
| Operating Income | $130.6M | $110.3M | $212.9M | $168.5M | $265.3M | |
| Net Interest Expenses | $34.4M | $30.5M | $51.2M | $56.2M | $176.3M | |
| EBT. Incl. Unusual Items | $407.3M | $449.6M | $121.7M | $299M | $1B | |
| Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
| Income Tax Expense | $107.3M | $96.3M | $51.3M | $87.3M | $292.1M | |
| Net Income to Company | $300M | $353.3M | $70.4M | $211.7M | $732.6M | |
| Minority Interest in Earnings | $397K | -$1.3M | -$3.4M | -$6.4M | -$8M | |
| Net Income to Common Excl Extra Items | $300.4M | $352.1M | $67.1M | $205.3M | $724.6M | |
| Basic EPS (Cont. Ops) | $58.30 | $70.65 | $13.83 | $43.96 | $164.62 | |
| Diluted EPS (Cont. Ops) | $58.13 | $70.45 | $13.79 | $43.82 | $163.40 | |
| Weighted Average Basic Share | $5.1M | $5M | $4.8M | $4.6M | $4.4M | |
| Weighted Average Diluted Share | $5.1M | $5M | $4.8M | $4.7M | $4.4M | |
| EBITDA | $696.7M | $719.5M | $504.8M | $665.2M | $1.4B | |
| EBIT | $445.6M | $483.6M | $176.1M | $362.3M | $1.2B | |
| Revenue (Reported) | $2.9B | $3.2B | $3.9B | $4.4B | $4.8B | |
| Operating Income (Reported) | $130.6M | $110.3M | $212.9M | $168.5M | $265.3M | |
| Operating Income (Adjusted) | $445.6M | $483.6M | $176.1M | $362.3M | $1.2B | |
| Period Ending | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | |
|---|---|---|---|---|---|---|
| Revenue | $787M | $862.9M | $1.1B | $1.2B | $1.2B | |
| Revenue Growth (YoY) | 3.08% | 9.65% | 23.3% | 9.66% | 6.77% | |
| Cost of Revenues | $501M | $560.7M | $715.6M | $826.3M | $845.9M | |
| Gross Profit | $286M | $302.2M | $348.4M | $340.5M | $399.9M | |
| Gross Profit Margin | 36.35% | 35.02% | 32.74% | 29.19% | 32.1% | |
| R&D Expenses | -- | -- | -- | -- | -- | |
| Selling, General & Admin | $209.2M | $244.7M | $245.2M | $266M | $274.9M | |
| Other Inc / (Exp) | $286.3M | $87M | -$28.5M | $54.8M | $707.8M | |
| Operating Expenses | $239.5M | $278.3M | $274.3M | $299.7M | $303.8M | |
| Operating Income | $46.5M | $23.9M | $74.1M | $40.8M | $96M | |
| Net Interest Expenses | $15.1M | $8.1M | $14.4M | $23M | $46.2M | |
| EBT. Incl. Unusual Items | $317.7M | $102.9M | $31.1M | $72.6M | $757.6M | |
| Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
| Income Tax Expense | $80.8M | $17.8M | $24.5M | $16.9M | $206M | |
| Net Income to Company | $236.9M | $85.1M | $6.6M | $55.7M | $551.6M | |
| Minority Interest in Earnings | $198K | -$402K | -$483K | -$2.4M | -$2.8M | |
| Net Income to Common Excl Extra Items | $237.1M | $84.7M | $6.2M | $53.3M | $548.8M | |
| Basic EPS (Cont. Ops) | $47.45 | $17.14 | $1.28 | $11.73 | $126.63 | |
| Diluted EPS (Cont. Ops) | $47.34 | $17.10 | $1.28 | $11.68 | $125.55 | |
| Weighted Average Basic Share | $5M | $4.9M | $4.8M | $4.5M | $4.3M | |
| Weighted Average Diluted Share | $5M | $4.9M | $4.8M | $4.5M | $4.4M | |
| EBITDA | $384.1M | $165.2M | $221M | $149.3M | $875.1M | |
| EBIT | $333.8M | $111.7M | $46.6M | $98M | $807.1M | |
| Revenue (Reported) | $787M | $862.9M | $1.1B | $1.2B | $1.2B | |
| Operating Income (Reported) | $46.5M | $23.9M | $74.1M | $40.8M | $96M | |
| Operating Income (Adjusted) | $333.8M | $111.7M | $46.6M | $98M | $807.1M | |
| Period Ending | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | |
|---|---|---|---|---|---|---|
| Revenue | $2.9B | $3.2B | $3.9B | $4.4B | $4.8B | |
| Revenue Growth (YoY) | -- | -- | -- | -- | -- | |
| Cost of Revenues | $1.9B | $2.1B | $2.7B | $3.1B | $3.3B | |
| Gross Profit | $977M | $1.1B | $1.3B | $1.3B | $1.5B | |
| Gross Profit Margin | -- | -- | -- | -- | -- | |
| R&D Expenses | -- | -- | -- | -- | -- | |
| Selling, General & Admin | $715.4M | $831.9M | $921.7M | $1B | $1.1B | |
| Other Inc / (Exp) | $311.1M | $369.8M | -$40M | $186.7M | $935.7M | |
| Operating Expenses | $846.4M | $961.1M | $1.1B | $1.1B | $1.2B | |
| Operating Income | $130.6M | $110.3M | $212.9M | $168.5M | $265.3M | |
| Net Interest Expenses | $34.4M | $30.5M | $51.2M | $56.2M | $176.3M | |
| EBT. Incl. Unusual Items | $407.3M | $449.6M | $121.7M | $299M | $1B | |
| Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
| Income Tax Expense | $107.3M | $96.3M | $51.3M | $87.3M | $292.1M | |
| Net Income to Company | $300M | $353.3M | $70.4M | $211.7M | $732.6M | |
| Minority Interest in Earnings | $397K | -$1.3M | -$3.4M | -$6.4M | -$8M | |
| Net Income to Common Excl Extra Items | $300.4M | $352.1M | $67.1M | $205.3M | $724.6M | |
| Basic EPS (Cont. Ops) | $59.99 | $70.63 | $13.61 | $43.58 | $166.25 | |
| Diluted EPS (Cont. Ops) | $59.84 | $70.43 | $13.54 | $43.43 | $164.90 | |
| Weighted Average Basic Share | ||||||
| Weighted Average Diluted Share | ||||||
| EBITDA | $696.7M | $719.6M | $504.8M | $665.2M | $1.4B | |
| EBIT | $445.6M | $483.6M | $176.1M | $362.3M | $1.2B | |
| Revenue (Reported) | $2.9B | $3.2B | $3.9B | $4.4B | $4.8B | |
| Operating Income (Reported) | $130.6M | $110.3M | $212.9M | $168.5M | $265.3M | |
| Operating Income (Adjusted) | $445.6M | $483.6M | $176.1M | $362.3M | $1.2B | |
| Period Ending | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | 2025-12-31 | |
|---|---|---|---|---|---|---|
| Revenue | $3.2B | $3.9B | $4.4B | $4.8B | -- | |
| Revenue Growth (YoY) | -- | -- | -- | -- | -- | |
| Cost of Revenues | $2.1B | $2.7B | $3.1B | $3.3B | -- | |
| Gross Profit | $1.1B | $1.3B | $1.3B | $1.5B | -- | |
| Gross Profit Margin | -- | -- | -- | -- | -- | |
| R&D Expenses | -- | -- | -- | -- | -- | |
| Selling, General & Admin | $831.9M | $921.7M | $1B | $1.1B | -- | |
| Other Inc / (Exp) | $369.8M | -$40M | $186.7M | $935.7M | -- | |
| Operating Expenses | $961.1M | $1.1B | $1.1B | $1.2B | -- | |
| Operating Income | $110.3M | $212.9M | $168.5M | $265.3M | -- | |
| Net Interest Expenses | $30.5M | $51.2M | $56.2M | $176.3M | -- | |
| EBT. Incl. Unusual Items | $449.6M | $121.7M | $299M | $1B | -- | |
| Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
| Income Tax Expense | $96.3M | $51.3M | $87.3M | $292.1M | -- | |
| Net Income to Company | $353.3M | $70.4M | $211.7M | $732.6M | -- | |
| Minority Interest in Earnings | -$1.3M | -$3.4M | -$6.4M | -$8M | -- | |
| Net Income to Common Excl Extra Items | $352.1M | $67.1M | $205.3M | $724.6M | -- | |
| Basic EPS (Cont. Ops) | $70.63 | $13.61 | $43.58 | $166.25 | -- | |
| Diluted EPS (Cont. Ops) | $70.43 | $13.54 | $43.43 | $164.90 | -- | |
| Weighted Average Basic Share | $19.8M | $19.3M | $18.6M | $17.5M | -- | |
| Weighted Average Diluted Share | $19.9M | $19.3M | $18.6M | $17.6M | -- | |
| EBITDA | $719.6M | $504.8M | $665.2M | $1.4B | -- | |
| EBIT | $483.6M | $176.1M | $362.3M | $1.2B | -- | |
| Revenue (Reported) | $3.2B | $3.9B | $4.4B | $4.8B | -- | |
| Operating Income (Reported) | $110.3M | $212.9M | $168.5M | $265.3M | -- | |
| Operating Income (Adjusted) | $483.6M | $176.1M | $362.3M | $1.2B | -- | |
| Period Ending | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | |
|---|---|---|---|---|---|---|
| Cash and Equivalents | $414M | $145.9M | $169.3M | $169.9M | $260.9M | |
| Short Term Investments | $587.6M | $824.4M | $622.4M | $697M | $858.7M | |
| Accounts Receivable, Net | -- | $589.6M | $504.8M | $496.2M | $477.8M | |
| Inventory | $120.6M | $141.5M | $226.8M | $297.2M | $295.8M | |
| Prepaid Expenses | $75.5M | $81.7M | $97.5M | $119.9M | $116.5M | |
| Other Current Assets | $942K | $1.2M | $1.5M | $1.3M | $7.6M | |
| Total Current Assets | $1.8B | $1.8B | $1.7B | $1.8B | $2.1B | |
| Property Plant And Equipment | $840.8M | $906.1M | $932.4M | $969.5M | $937.8M | |
| Long-Term Investments | $155.8M | $155.4M | $186.4M | $186.5M | $169.1M | |
| Goodwill | $1.5B | $1.6B | $1.6B | $1.5B | $1.5B | |
| Other Intangibles | $325.1M | $389.3M | $340.4M | $300.1M | $221M | |
| Other Long-Term Assets | $146.8M | $163.5M | $189.1M | $233M | $231.2M | |
| Total Assets | $6.4B | $7.4B | $6.6B | $7.2B | $7.7B | |
| Accounts Payable | $106.2M | $127M | $136.2M | $154.5M | $160.4M | |
| Accrued Expenses | $278.5M | $277.3M | $218.5M | $237.2M | $231.3M | |
| Current Portion Of Long-Term Debt | $6.5M | $141.7M | $155.8M | $66.8M | $26.6M | |
| Current Portion Of Capital Lease Obligations | $86.8M | $77.7M | $70M | $64.2M | $58.2M | |
| Other Current Liabilities | -- | -- | -- | -- | -- | |
| Total Current Liabilities | $949.6M | $1.2B | $1.1B | $1.2B | $1.2B | |
| Long-Term Debt | $506.1M | $525.8M | $570.5M | $745.1M | $721.6M | |
| Capital Leases | -- | -- | -- | -- | -- | |
| Total Liabilities | $2.7B | $3B | $2.8B | $3.2B | $3.3B | |
| Common Stock | $20M | $20M | $20M | $20M | $20M | |
| Other Common Equity Adj | -$1.7M | -$1.5M | $2.2M | -$2.1M | -$1.1M | |
| Common Equity | $3.8B | $4.4B | $3.7B | $4B | $4.3B | |
| Total Preferred Equity | -- | -- | -- | -- | -- | |
| Minority Interest, Total | $7.1M | $26.4M | $43.1M | $50.3M | $74M | |
| Total Equity | $3.8B | $4.4B | $3.8B | $4B | $4.3B | |
| Total Liabilities and Equity | $6.4B | $7.4B | $6.6B | $7.2B | $7.7B | |
| Cash and Short Terms | $1B | $970.3M | $791.7M | $866.9M | $1.1B | |
| Total Debt | $512.6M | $667.5M | $726.4M | $811.8M | $748.2M | |
| Period Ending | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | |
|---|---|---|---|---|---|---|
| Cash and Equivalents | $414M | $145.9M | $169.3M | $169.9M | $260.9M | |
| Short Term Investments | $587.6M | $824.4M | $622.4M | $697M | $858.7M | |
| Accounts Receivable, Net | -- | $589.6M | $504.8M | $496.2M | $477.8M | |
| Inventory | $120.6M | $141.5M | $226.8M | $297.2M | $295.8M | |
| Prepaid Expenses | $75.5M | $81.7M | $97.5M | $119.9M | $116.5M | |
| Other Current Assets | $942K | $1.2M | $1.5M | $1.3M | $7.6M | |
| Total Current Assets | $1.8B | $1.8B | $1.7B | $1.8B | $2.1B | |
| Property Plant And Equipment | $840.8M | $906.1M | $932.4M | $969.5M | $937.8M | |
| Long-Term Investments | $155.8M | $155.4M | $186.4M | $186.5M | $169.1M | |
| Goodwill | $1.5B | $1.6B | $1.6B | $1.5B | $1.5B | |
| Other Intangibles | $325.1M | $389.3M | $340.4M | $300.1M | $221M | |
| Other Long-Term Assets | $146.8M | $163.5M | $189.1M | $233M | $231.2M | |
| Total Assets | $6.4B | $7.4B | $6.6B | $7.2B | $7.7B | |
| Accounts Payable | $106.2M | $127M | $136.2M | $154.5M | $160.4M | |
| Accrued Expenses | $278.5M | $277.3M | $218.5M | $237.2M | $231.3M | |
| Current Portion Of Long-Term Debt | $6.5M | $141.7M | $155.8M | $66.8M | $26.6M | |
| Current Portion Of Capital Lease Obligations | $86.8M | $77.7M | $70M | $64.2M | $58.2M | |
| Other Current Liabilities | -- | -- | -- | -- | -- | |
| Total Current Liabilities | $949.6M | $1.2B | $1.1B | $1.2B | $1.2B | |
| Long-Term Debt | $506.1M | $525.8M | $570.5M | $745.1M | $721.6M | |
| Capital Leases | -- | -- | -- | -- | -- | |
| Total Liabilities | $2.7B | $3B | $2.8B | $3.2B | $3.3B | |
| Common Stock | $20M | $20M | $20M | $20M | $20M | |
| Other Common Equity Adj | -$1.7M | -$1.5M | $2.2M | -$2.1M | -$1.1M | |
| Common Equity | -- | -- | -- | -- | -- | |
| Total Preferred Equity | -- | -- | -- | -- | -- | |
| Minority Interest, Total | $7.1M | $26.4M | $43.1M | $50.3M | $74M | |
| Total Equity | $3.8B | $4.4B | $3.8B | $4B | $4.3B | |
| Total Liabilities and Equity | $6.4B | $7.4B | $6.6B | $7.2B | $7.7B | |
| Cash and Short Terms | $1B | $970.3M | $791.7M | $866.9M | $1.1B | |
| Total Debt | $512.6M | $667.5M | $726.4M | $811.8M | $748.2M | |
| Period Ending | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | |
|---|---|---|---|---|---|---|
| Net Income to Stockholders | $300M | $353.3M | $70.4M | $211.7M | $732.6M | |
| Depreciation & Amoritzation | $251.2M | $236M | $328.7M | $302.9M | $237.2M | |
| Stock-Based Compensation | $6.3M | $5.7M | $6.1M | $6.7M | $6.3M | |
| Change in Accounts Receivable | $61.3M | -$59.3M | $45.5M | $8.2M | $11.3M | |
| Change in Inventories | $3.8M | $4.6M | -$64.3M | -$62.9M | $8.3M | |
| Cash From Operations | $210.7M | $202.4M | $235.6M | $259.9M | $407M | |
| Capital Expenditures | $69.6M | $162.5M | $82.7M | $93.4M | $82.9M | |
| Cash Acquisitions | $193.1M | -$350.1M | -$163.9M | -$87.9M | -$285K | |
| Cash From Investing | $199.4M | -$494.6M | -$184.1M | -$153M | -$62.3M | |
| Dividends Paid (Ex Special Dividend) | -$30M | -$30.1M | -$30.7M | -$31M | -$30.3M | |
| Special Dividend Paid | ||||||
| Long-Term Debt Issued | $80M | $204.9M | $80.3M | $293.4M | $1.4M | |
| Long-Term Debt Repaid | -$97.5M | -$60.2M | -$16.6M | -$230.8M | -$78.2M | |
| Repurchase of Common Stock | -$161.8M | -$55.7M | -$71.4M | -$193.2M | -$114.1M | |
| Other Financing Activities | -$19.8M | -$27.8M | $20.3M | $61.7M | -$19.7M | |
| Cash From Financing | -$204M | $31M | -$18.1M | -$99.8M | -$241M | |
| Beginning Cash (CF) | $214M | $423.1M | $158.8M | $190.4M | $201.9M | |
| Foreign Exchange Rate Adjustment | -- | -- | -- | -- | -- | |
| Additions / Reductions | $206M | -$261.2M | $33.4M | $7.1M | $103.7M | |
| Ending Cash (CF) | $423.1M | $158.8M | $190.4M | $201.9M | $297.9M | |
| Levered Free Cash Flow | $141.1M | $39.9M | $152.9M | $166.4M | $324.1M | |
| Period Ending | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | |
|---|---|---|---|---|---|---|
| Net Income to Stockholders | $236.9M | $85.1M | $6.6M | $55.7M | $551.6M | |
| Depreciation & Amoritzation | $50.4M | $53.5M | $174.4M | $51.3M | $68M | |
| Stock-Based Compensation | $1.6M | $973K | $1.6M | $1.7M | $1.6M | |
| Change in Accounts Receivable | -$77.8M | -$31.9M | -$13.4M | -$4.2M | -$5K | |
| Change in Inventories | $3.7M | -$16.6M | -$16.8M | -$15.7M | $16.4M | |
| Cash From Operations | -$30.2M | $5.2M | $31.9M | $57.3M | $116.3M | |
| Capital Expenditures | $13.5M | $21.6M | $25.6M | $32.3M | $25.2M | |
| Cash Acquisitions | $219.6M | -$79.9M | -$3.7M | $1.9M | $5.9M | |
| Cash From Investing | $186.6M | -$74.2M | -$12.4M | -$33.5M | -$26.7M | |
| Dividends Paid (Ex Special Dividend) | -$7.1M | -$7.5M | -$7.6M | -$7.4M | -$7.4M | |
| Special Dividend Paid | -- | -- | -- | -- | -- | |
| Long-Term Debt Issued | -$4.5M | $143.4M | -$13.1M | -$56.4M | -$9.4M | |
| Long-Term Debt Repaid | -$5.4M | -$28.3M | $5M | $27M | -$27.9M | |
| Repurchase of Common Stock | -$38.7M | -$33.8M | -$16.8M | -$60.9M | -$15.9M | |
| Other Financing Activities | -$14.5M | $5.3M | $24.1M | $67.7M | -$3.9M | |
| Cash From Financing | -$50.3M | $79.1M | -$9.9M | -$30.1M | -$64.7M | |
| Beginning Cash (CF) | $311.3M | $148.9M | $170.9M | $200.6M | $282.2M | |
| Foreign Exchange Rate Adjustment | $5.7M | -$121K | $10M | $7.6M | -$9.4M | |
| Additions / Reductions | $106.1M | $10M | $9.6M | -$6.3M | $25M | |
| Ending Cash (CF) | $423.1M | $158.8M | $190.4M | $201.9M | $297.9M | |
| Levered Free Cash Flow | -$43.7M | -$16.4M | $6.4M | $25.1M | $91.1M | |
| Period Ending | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | |
|---|---|---|---|---|---|---|
| Net Income to Stockholders | $300M | $353.3M | $70.4M | $211.7M | $732.6M | |
| Depreciation & Amoritzation | $251.2M | $236M | $328.7M | $302.9M | $237.2M | |
| Stock-Based Compensation | $6.3M | $5.7M | $6.1M | $6.7M | $6.3M | |
| Change in Accounts Receivable | $61.3M | -$59.3M | $45.5M | $8.2M | $11.3M | |
| Change in Inventories | $3.8M | $4.6M | -$64.3M | -$62.9M | $8.3M | |
| Cash From Operations | $210.7M | $202.4M | $235.6M | $259.9M | $407M | |
| Capital Expenditures | $69.6M | $162.5M | $82.7M | $93.4M | $82.9M | |
| Cash Acquisitions | $193.1M | -$350.1M | -$163.9M | -$87.9M | -$285K | |
| Cash From Investing | $199.4M | -$494.6M | -$184.1M | -$153M | -$62.3M | |
| Dividends Paid (Ex Special Dividend) | -$30M | -$30.1M | -$30.7M | -$31M | -$30.3M | |
| Special Dividend Paid | ||||||
| Long-Term Debt Issued | $80M | $204.9M | -- | $293.4M | $1.4M | |
| Long-Term Debt Repaid | -$97.5M | -$60.2M | -$16.6M | -$230.8M | -$78.2M | |
| Repurchase of Common Stock | -$161.8M | -$55.7M | -$71.4M | -$193.2M | -$114.1M | |
| Other Financing Activities | -$19.8M | -$27.8M | $20.3M | $61.7M | -$19.7M | |
| Cash From Financing | -$204M | $31M | -$18.1M | -$99.8M | -$241M | |
| Beginning Cash (CF) | -- | -- | -- | -- | -- | |
| Foreign Exchange Rate Adjustment | -- | -- | -- | -- | -- | |
| Additions / Reductions | $206M | -$261.2M | $33.4M | $7.1M | $103.7M | |
| Ending Cash (CF) | -- | -- | -- | -- | -- | |
| Levered Free Cash Flow | $141.1M | $39.9M | $152.9M | $166.4M | $324.1M | |
| Period Ending | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | 2025-12-31 | |
|---|---|---|---|---|---|---|
| Net Income to Stockholders | $353.3M | $70.4M | $211.7M | $732.6M | -- | |
| Depreciation & Amoritzation | $236M | $328.7M | $302.9M | $237.2M | -- | |
| Stock-Based Compensation | $5.7M | $6.1M | $6.7M | $6.3M | -- | |
| Change in Accounts Receivable | -$59.3M | $45.5M | $8.2M | $11.3M | -- | |
| Change in Inventories | $4.6M | -$64.3M | -$62.9M | $8.3M | -- | |
| Cash From Operations | $202.4M | $235.6M | $259.9M | $407M | -- | |
| Capital Expenditures | $162.5M | $82.7M | $93.4M | $82.9M | -- | |
| Cash Acquisitions | -$350.1M | -$163.9M | -$87.9M | -$285K | -- | |
| Cash From Investing | -$494.6M | -$184.1M | -$153M | -$62.3M | -- | |
| Dividends Paid (Ex Special Dividend) | -$30.1M | -$30.7M | -$31M | -$30.3M | -- | |
| Special Dividend Paid | -- | -- | -- | -- | -- | |
| Long-Term Debt Issued | $204.9M | $80.3M | $293.4M | $1.4M | -- | |
| Long-Term Debt Repaid | -$60.2M | -$16.6M | -$230.8M | -$78.2M | -- | |
| Repurchase of Common Stock | -$55.7M | -$71.4M | -$193.2M | -$114.1M | -- | |
| Other Financing Activities | -$27.8M | $20.3M | $61.7M | -$19.7M | -- | |
| Cash From Financing | $31M | -$18.1M | -$99.8M | -$241M | -- | |
| Beginning Cash (CF) | $1.1B | $634.2M | $698.2M | $850.7M | -- | |
| Foreign Exchange Rate Adjustment | -$3M | -$1.8M | $4.4M | -$7.7M | -- | |
| Additions / Reductions | -$261.2M | $33.4M | $7.1M | $103.7M | -- | |
| Ending Cash (CF) | $805.9M | $665.8M | $709.6M | $946.7M | -- | |
| Levered Free Cash Flow | $39.9M | $152.9M | $166.4M | $324.1M | -- | |
Get GHC Stock Alert
Signup to receive the latest stock alerts
Financial Ratios
GHC
Sector
P/E ratio
5.70x
16.26x
PEG ratio
0.02x
0.19x
P/B ratio
0.96x
1.39x
Price / LTM sales
0.86x
0.66x
Growth Metrics
GHC
Sector
Revenue growth
6.77%
1.82%
Earnings growth
974.91%
0.82%
Revenue (5-year growth)
10.32%
3.61%
Earnings forecast
$22.12
$0.30
Profitability
GHC
Sector
Profitability FY 2024
$1.5B
$485.8M
Return on invested capital
14.77%
4.91%
Return on assets
9.85%
3.03%
Return on equity
17.63%
7.42%
Earnings Date
Last Earnings Date
Feb
26
Next Earnings Date
May
1
Estimated Next Earnings Date
May
28
Balance Sheet
GHC
Sector
Total cash
$1.1B
$157.2M
Short term investments
$858.7M
$56.5M
Total assets
$7.7B
$1.6B
Long term debt
$748.2M
$156.1M
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Is Palantir a Good Stock to Buy?
Palantir Technologies (PLTR) stock soared to its highest level in…
Why Is Sportradar Stock Going Up?
Sportradar (NASDAQ:SRAD) should be on your radar for a stock…
Stock Ideas
Buy
55
Is AAPL Stock a Buy?
Market Cap: $3.3T
P/E Ratio: 36x
Buy
53
Is MSFT Stock a Buy?
Market Cap: $2.9T
P/E Ratio: 33x
Buy
51
Is NVDA Stock a Buy?
Market Cap: $2.9T
P/E Ratio: 40x
Alerts
Sell
50
RGC alert for Mar 22
Regencell Bioscience Holdings [RGC] is up 27.82% over the past day.
Sell
36
VMI alert for Mar 22
Valmont Industries [VMI] is down 12.54% over the past day.
Buy
61
ALNY alert for Mar 22
Alnylam Pharmaceuticals [ALNY] is up 11.7% over the past day.
THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS
Show me the best stock
